Onkologie. 2011:5(1):49-52

The role of stereotactic biopsy in the diagnostic workup of brain tumor

Jan Chrastina1, Zdeněk Novák1, Radim Jančálek1, Ivo Říha1, Bronislava Slaná2, Markéta Hermanová2, Věra Feitová3
1 Neurochirurgická klinika LF MU FN u sv. Anny v Brně
2 I. patologickoanatomický ústav LF MU FN u sv. Anny v Brně
3 Klinika zobrazovacích metod LF MU FN u sv. Anny v Brně

Study aim: Histological verification is a prerequisite for adequate therapy of brain tumors. Study presents the experience with stereotactic

biopsy of brain tumors paying attention to diagnostic utility, correlation of findings with tumor resection and surgical safety.

Methods: Brain tumor biopsy using stereotactic frame based system (deep and small lesions) was performed in 106 patients and frameless

neuronavigation system BrainLab (superficially located lesions) was used in 20 patients.

Results: Diagnostic efficiency was 96,3 % in frame based system and 100 % in frameless system. The incidence of complications was

1,8 % in frame based biopsies. There was one asymptomatic haematoma in frameless biopsy patients. Suspected brain tumor was not

proven in 12,8 % of patient. There was correlation of histological findings in specimens taken during stereotactic biopsy and open tumor

resection (10 patients) in all except one patient (malignant glioma grading).

Conclusions: Frameless and neuronavigation based tumor biopsy is a safe procedure beneficial for the treatment of brain tumor patiens.

The decision about the use of frame based or frameless system depends on lesion location (frame based system in deep lesions), lesion

extent (frameless system in extensive subcortical tumors) and planned treatment steps.

Keywords: brain tumors, stereotaxy, frameless technique, biopsy

Published: February 25, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chrastina J, Novák Z, Jančálek R, Říha I, Slaná B, Hermanová M, Feitová V. The role of stereotactic biopsy in the diagnostic workup of brain tumor. Onkologie. 2011;5(1):49-52.
Download citation

References

  1. Greenberg MS. Handbook of neurosurgery. Fourth edition. Lakeland, Florida: Greenberg Graphics, 1997: 354.
  2. Linskey ME. The changing role of stereotaxis in surgical neurooncology. J Neurooncol 2004; 69: 35-54. Go to original source... Go to PubMed...
  3. Stranjalis G, Protopapa D, Sakas DE, Chondros D. Stereotactic biopsy in the era of advanced neuroimaging. Does the minimal therapeutic gain justify its current wide use? Minim Invasive Neurosurgery 2003; 46: 90-93. Go to original source... Go to PubMed...
  4. Ebel H, Rust DS, Scheuerle A. Value of stereotaxy in neurosurgery. Indications and analysis of results of 71 cases. Nervenarzt 1996; 67: 650-658. Go to original source... Go to PubMed...
  5. Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ. The risk of haemorrhage after inmage guided stereotactic biopsy of intra- axial brain tumours - a prospective study. Acta Neurochir (Wien) 2001; 143: 539-545. Go to original source... Go to PubMed...
  6. Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ. Safety and efficacy of frameless and frame based intracranial biopsy techniques. Acta Neurochirurgica (Wien) 2008; 150: 23-29. Go to original source... Go to PubMed...
  7. Nasser JA, Confort CI, Ferraz A, Esperanca JC, Duarte F. Image - guided stereotactic biopsy of central nervous system lesions. Arg Neuropsiquiatr 1998; 56: 206-211. Go to original source... Go to PubMed...
  8. Hertel F, Feiden W, Bettag M. The value of micro Doppler in stereotactic brain biopsy. Minim Invasive Neurosurg 2005; 48: 165-168. Go to original source... Go to PubMed...
  9. Zhang YQ, Zhao GG, Li KC, Li JY, Yu T, Wang L, Li YJ. MRI guided stereotactic biopsy for questionable diseases of the brain. Zhonghua Wai Ke Za Zhi 2003; 41: 667-669.
  10. Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Accuracy of frameless and frame based image guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 2005; 27: 358-362. Go to original source... Go to PubMed...
  11. Sawin PD, Hitchon PW, Follet KA, Torner JC. Computed imaging - assisted stereotactic brain biopsy: a risk analysis of 225 cosecutive cases. Surg Neurol 1998; 49: 640-649. Go to original source... Go to PubMed...
  12. Lundsford LD, Niranjan A, Khan AA, Kondziolka D. Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact Funct Neurosurg 2008; 86: 278-287. Go to original source... Go to PubMed...
  13. Woodworth GF, Mc Girt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD. Frameless image guided biopsy procedure: diagnostic yield, surgical morbidity and comparison with frame based technique. J Neurosurg 2006; 104: 233-237. Go to original source... Go to PubMed...
  14. Gralla J, Nimsky C, Buchfelder M, Fahlbusch R, Ganslandt O. Frameless stereotactic brain biopsy procedures using the Stealth Station. Indications, accuracy and results. Zentralbl Neurochir 2003; 64: 166-170. Go to original source... Go to PubMed...
  15. Law M. Advanced imaging techniques in brain tumors. Cancer Imaging 2009; 9: S4-9. Go to original source... Go to PubMed...
  16. Essig M, Giesel F, Stieltjes B, Weber MA. Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy). Radiologe 2007; 47: 513-519. Go to original source... Go to PubMed...
  17. Martínez - Bisbal MC, Celda B. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. Q J Nucl Med Mol Imaging 2009; 53: 618-630. Go to PubMed...
  18. Setzer M, Herminghaus S, Marquardt G, Tews DS, Pilatus U, Seifert V, Zanella F, Lanfermann H. Acta Neurochir (Wien) 2007; 149: 379-386.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.